Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
about
The possibility of resistant hypertension during the treatment of hypertensive patients.Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus.Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism.
P2860
Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
@en
type
label
Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
@en
prefLabel
Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
@en
P2860
P356
P1476
Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
@en
P2093
Atsuhisa Sato
P2860
P2888
P304
P356
10.1038/HR.2012.182
P577
2012-11-22T00:00:00Z